Variability of response to antiplatelet therapy: what should we do next?
Shantsila
Eduard
E
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B187QH, England, UK. shantsila@yandex.ru
Lip
Gregory Y H
GY
D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004351:Drug Resistance; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D010979:Platelet Function Tests / Q000379:methods; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin